November 7, 2017 / 1:13 PM / 12 days ago

BRIEF-Infinity Q3 loss per share $0.14

Nov 7 (Reuters) - Infinity Pharmaceuticals Inc:

* Infinity provides company update and reports third quarter 2017 financial results

* Q3 loss per share $0.14

* Q3 earnings per share view $-0.21 -- Thomson Reuters I/B/E/S

* Q3 revenue $6.0 million

* Q3 revenue view $14.7 million -- Thomson Reuters I/B/E/S

* Infinity Pharmaceuticals Inc - ‍infinity expects net loss for 2017 to range from $40 million to $50 million​

* Infinity Pharmaceuticals - ‍expects to end 2017 with a cash, cash equivalents and available-for-sale securities balance ranging from $40 million to $50 million​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below